chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Drug ineffective; COVID after their primary series of Pfizer-COVID 19 vaccine; This is a spontaneous report received from a non-contactable consumer (patient) from medical information team for a Pfizer sponsored program (159558).   A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "Drug ineffective"; COVID-19 (medically significant), outcome "unknown", described as "COVID after their primary series of Pfizer-COVID 19 vaccine". The patient inquired if someone had COVID after their primary series of Pfizer-COVID 19 vaccine, when can they get the booster dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Redness, pain and swelling that spread to wrist that lasted 3 weeks. Was seen by MD and prescribed oral steroids.
pt immunized 23JAN95 & 25JAN parent reported to MD that had fever of 101 for the past 2 days & immunization site red & swollen;MD visit on 26JAN local rxn measured 3cm x 6cm;t98.8 DPH/ice packs rx;lorabid cont recovered
BODY ACHES; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination.  The batch number was not reported and has been requested.  Concomitant medications included ibuprofen. On 09-APR-2021, the patient experienced body aches. On 09-APR-2021, the patient experienced headache. On 09-APR-2021, the patient experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body aches, headache, and nausea. This report was non-serious.
I took the second shot yesterday, now now I'm running a101.4 temperature; Feel this cruddy.; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (I took the second shot yesterday, now now I'm running a101.4 temperature) and ILLNESS (Feel this cruddy.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (I took the second shot yesterday, now now I'm running a101.4 temperature) and ILLNESS (Feel this cruddy.). At the time of the report, PYREXIA (I took the second shot yesterday, now now I'm running a101.4 temperature) and ILLNESS (Feel this cruddy.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.4 (High) High.         No Concomitant medication was reported No treatment Medication was reported
I tested positive for COVID-19 on 11/20/22. I had body aches, congestion, and a fever. I thought I had the flu. I started having difficulty breathing and had to go to the emergency room and was admitted to the hospital. They gave me PAXLOVID, albuterol, DECADRON and ROBITUSSIN with codeine. I was also taking TYLENOL as needed. I still have shortness of breath with exertion.
PARTIAL DOSE ADMINISTRED; This spontaneous report received from a pharmacist . The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no history reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced partial dose administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of partial dose administered was not reported. This report was non-serious.
Just 3 days before my second injection I completely lost my taste; low-grade fever; Facial flushing; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), FLUSHING (Facial flushing), AGEUSIA (Just 3 days before my second injection I completely lost my taste) and PYREXIA (low-grade fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Allergic to Cephalosporins: resulted in hives.), Allergy to antibiotic (Allergic to Bactrim.), Drug allergy (Allergic to Sulfa.), Iodine allergy, Allergy to antibiotic (Allergic to Erythromycin.), Allergy to antibiotic (Allergic to Cipro.), Drug allergy (Allergic to Prednisone.) and Allergy to antibiotic (Resulted in Urticaria, Swollen tongue.). Concomitant products included NADOLOL (CORGARD), ATORVASTATIN CALCIUM (LIPITOR) and RALOXIFENE HYDROCHLORIDE (EVISTA) for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 27-Jan-2021, the patient experienced FLUSHING (Facial flushing) and PYREXIA (low-grade fever). On an unknown date, the patient experienced AGEUSIA (Just 3 days before my second injection I completely lost my taste). At the time of the report, VACCINATION SITE PAIN (sore arm), FLUSHING (Facial flushing), AGEUSIA (Just 3 days before my second injection I completely lost my taste) and PYREXIA (low-grade fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.2 - 99.5 (Inconclusive) 99.2 - 99.5. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-245849 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Jul-2021: Follow-up received on 05-JUL-2021 : Lab data, Concomitant medications, Events Outcome were Updated.
shortness of breath/can't breathe/anxious maybe panic attack; increased heart rate; foggy mind; vertigo (really dizzy); insomnia; can't breathe/anxious maybe panic attack; can't breathe/anxious maybe panic attack; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath/can't breathe/anxious maybe panic attack), HEART RATE INCREASED (increased heart rate), FEELING ABNORMAL (foggy mind), VERTIGO (vertigo (really dizzy)) and INSOMNIA (insomnia) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced DYSPNOEA (shortness of breath/can't breathe/anxious maybe panic attack), HEART RATE INCREASED (increased heart rate), FEELING ABNORMAL (foggy mind), VERTIGO (vertigo (really dizzy)), INSOMNIA (insomnia), DYSPNOEA (can't breathe/anxious maybe panic attack), PANIC ATTACK (can't breathe/anxious maybe panic attack) and CHILLS (chills). On 15-Apr-2021, CHILLS (chills) had resolved. At the time of the report, DYSPNOEA (shortness of breath/can't breathe/anxious maybe panic attack), HEART RATE INCREASED (increased heart rate), FEELING ABNORMAL (foggy mind), VERTIGO (vertigo (really dizzy)), INSOMNIA (insomnia), DYSPNOEA (can't breathe/anxious maybe panic attack) and PANIC ATTACK (can't breathe/anxious maybe panic attack) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Soreness in left arm, tiredness approximately 12 hours after receiving vaccine; symptoms were gone the next day.
Immediately after the injection, pt complained of pain down entire length of left arm. When checked one hour later pain had subsided after being iced but pt still reported painful.
pt recvd vax & devel arm pain; t 101; chills; arm edema & dec ROM; blotchy hives; tx w/ dph,apap,cool comp; "much better" next day;
Directly after the vaccine I had no issues. It wasn't until a few months later that I got COVID. My symptoms were a headache, fatigue and tired to the point that I felt exhausted, and a sore throat. I tested and tested positive for COVID. I also began to develop a cough and a slight fever. I called the doctor and got Paxlovid which I took for 5 days. My throat continued getting sore but I was feeling better. I still have a slight cough but I have been taking it very easy, and I get tired a bit faster now but it seems to be clearing.
This case was reported by a consumer via Regulatory Authority and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The case was self-reported by the patient. The age at vaccination was not reported. The reporter stated that, he/she had the 2 shots Shingles vaccine and had shingles. The reporter said shingles could happen even if you have had the vaccine. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding, time to onset and laboratory confirmation regarding shingles were unknown at the time of reporting.
1st shot taken at 2:30 p.m. on a Friday. By Saturday morning, I felt flu symptoms, severe headache, no appetite, unable to do anything but lie down. Heart palpitations started in the afternoon and continued for at least six hours. Felt like a party inside my chest, erratic, very scary.  next day I was completely wiped out and unable to do anything. 2nd shot I felt sick like the flu, bad for 24 hours and then mild for another 24. Booster shot I felt lousy but not as sick as with the first two shots.
Fever; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and FATIGUE (Tiredness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.    On 20-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 50 microgram. In December 2021, the patient experienced PYREXIA (Fever) and FATIGUE (Tiredness). At the time of the report, PYREXIA (Fever) and FATIGUE (Tiredness) outcome was unknown.            No Concomitant medications were reported.  No Treatment information was reported.
Acute confusion, then combative. Acute Psychosis. treated with precedx. reaohulot 24hrs.
The soreness after the flushot never went away. The pain is dull, and achy at rest or when there is movement. The pain gets worse when trying to use the arm for simple taks like driving, or even picking up something light. Arm weaknes, and shoulder stiffness. Pain is severe when doing any type of exercises.
Resident was found to be unresponsive he was then sent out to the hospital where an MRI confirmed the diagnosis of CVA.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  HYPOXEMIA  1/18/2023  -- RECURRENCE OF SAME SYMPTOMS
Initial and follow-up info has been received from a health professional concerning a 26 month old male with no known allergies, no illness at the time of vaccination and no past medical history who on 05/14/2001 was vaccinated with the first dose of varicella vaccine in left thigh. There was no concomitant medicine. On 05/29/2001, the child was seen at the physician's office. The child had 2 dozen lesions (blisters) on his abdomen, back and buttocks. The child was diagnosed with mild varicella and it was noted that the varicella was probably vaccine oriented. Subsequently, the child recovered. The reporter felt that the mild varicella was related to the therapy with varicella vaccine. No further info is available.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77-year-old male patient received BNT162b2 (BNT162B2), on 02Feb2022 at 11:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 76 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Colitis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
About 24-hours after getting the vaccination I started having pain and discomfort under my left arm. I got the vaccine in my left arm. Feels like a swollen lymph node. A little more than 48 hours after the vaccine I am now starting to feel a little bit of pain and discomfort in my right underarm area lymph nodes.
herpes zoster/Shingles; This is a spontaneous report from a contactable consumer (parent).  A 29-year-old female patient received BNT162B2, via an unspecified route of administration on 08Apr2021 (Batch/Lot number was not reported) at the age of 28 years old as 2nd dose, single for COVID-19 immunization. Medical history included anxiety; psychogenic non-epileptic seizures (PNES); polycystic ovary syndrome (PCOS); was previously diagnosed as being bipolar, but that diagnosis was changed; had chicken pox at age 2 and did not get the varicella vaccine. Concomitant medications included clonazepam (KLONOPIN) taken for anxiety, and on birth control for PCOS. The patient previously took BNT162B2 1st dose on an unspecified date for COVID-19 immunization. The patient received her second dose of the Pfizer COVID vaccine on 08Apr2021 (Thursday). On 26Apr2021 (Monday, 18 days later), she reported hives and blisters on her leg. At time of report, her primary care physician diagnosed her as having herpes zoster. Parent has no idea if patient's shingles is related to the vaccine but reported it as a possible adverse event. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
adverse event: shingles; symptoms include itch, nerve pain, muscle pain, rash/sores; onset at 3 days following covid vaccination treatment: Valacyclovir hcl 1 gram tablets (3 daily for 7 days); ibuprofen as needed; administered at 1 week following covid vaccination outcome: ongoing recovery
Seizure with fever - complex - required intubation secondary to apnea - No previous HX of seizures.  07/09/2007 MR received for o/n hospital stay 3/23-24/2007 after transport from another facility.  Child initially presented for an episode of decreased tone, staring without focusing or tracking, emesis, and lip cyanosis. Child presented in previous hospital ER then had some retractions and a 15 second episode of apnea.  Not responsive to pain, no gag, minimal corneal responsiveness.  He briefly desaturated to 62 and 75%. At this point he was intubated and prepared for transfer.    . Txd with anticonvusants for presumed seizure. Assessment: Presumed seizure in a previously normal child who had a prolonged period of unresponsiveness followed by apnea. ER record 4/11/2007 for a witnessed seizure with generalized motor activity with eyes rolling up, LOC and unresponsiveness.  This episode included a fever of 101.6, transient stiffness, and a left gaze x 20 min after event. Admitted and treated for seizure. Clinical impression: Fever. Seizure.
hard; my injection site became itchy; red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INDURATION (hard), INJECTION SITE PRURITUS (my injection site became itchy) and INJECTION SITE ERYTHEMA (red) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE INDURATION (hard), INJECTION SITE PRURITUS (my injection site became itchy) and INJECTION SITE ERYTHEMA (red). At the time of the report, INJECTION SITE INDURATION (hard), INJECTION SITE PRURITUS (my injection site became itchy) and INJECTION SITE ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.   Reporter did not allow further contact
No sense of taste in my mouth; It is like 75% has gone/no taste, no taste buds/after Covid-19 Vaccine it got worsened; No sense of taste in my mouth; It is like 75% has gone/no taste, no taste buds/after Covid-19 Vaccine it got worsened; chronic back problem, they seem to worsening, in his spine, in his joint, his back in lower back area and in his shoulder part; chronic back problem, they seem to worsening, in his spine, in his joint, his back in lower back area and in his shoulder part; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot Number: EL3247, expiration date unknown), via an unspecified route of administration on 05Feb2021 at the age of 65 years old at a single dose for COVID-19 immunization. The patient's medical history included ongoing arthritis, started experiencing this problem with my taste in Aug2020. Concomitant medications included acetaminophen for arthritis, cetirizine (tablet) at 1 DF, once a day, vitamin D1, vitamins and multivitamins. Patient stated on 05Feb2021, got first Pfizer shot. Patient noticed that they told him to come back in about three weeks. From 05Feb2021, they told him to come back on 26Feb2021. He said okay. First of 15 minutes they told him to stay there to see if he had any reactions. He was okay. He noticed in probably the last week and half though that he had a sense like no taste, no taste buds, and no sense of taste in his mouth. It is like 75% has gone on an unspecified date in 2021. Other symptoms are, patient got some chronic back problem, they seem to worsening, in his spine, in his joint, his back in lower back area and in his shoulder part area also on an unspecified date in 2021. Should he get his second shot coming up 26Feb2021, go ahead and get it?" was his question. Patient stated, "I am disabled vet (not clarified). I am like kind of regarded like 100% disabled vet. I am on 'test' in hospital where I got my shot. "Patient stated, "I just wanted to know if other people called in, told you about they start losing taste buds too, the sense of smell and taste." Patient stated, "I started experiencing this problem with my taste. It seems like around, probably Aug2020, I had like a some taste that I was losing but it seems like after I got this shot about when 4 months later, after I got the shot (Covid-19 Vaccine) I noticed it got worsened. But I am not running, no fever. I haven't had fever, cold or cough or chills or anything." The outcome of the events was unknown.
This case was reported by a nurse via call center representative and described the occurrence of agitation aggravated in a 65-year-old male patient who received FLULAVAL QUADRIVALENT (batch number 7929M, expiry date 30th April 2018). Co-suspect products included FLUZONE. The patient's past medical history included autism. In January 2018, the patient received FLULAVAL QUADRIVALENT. In October 2017, the patient received FLUZONE. On an unknown date, less than a year after receiving FLULAVAL QUADRIVALENT, the patient experienced agitation aggravated and anxiety. On an unknown date, the outcome of the agitation aggravated and anxiety were unknown. It was unknown if the reporter considered the agitation aggravated and anxiety to be related to FLULAVAL QUADRIVALENT. Additional information was reported as follows: The patient was diagnosed with autism after receiving FLUZONE and FLULAVAL QUADRIVALENT. No additional information was provided.
presents to the emergency department from the skilled nursing facility with reports of altered mentation.  Patient reports a cough with yellow sputum production.  She tested positive for COVID-19 on February 11th.  hypoxic on arrival with a saturation of a 80% on room air that improved with supplemental oxygen.  She had a chest x-ray which revealed multifocal pneumonia.  She was started on IV antibiotic therapy.   treated with steroids and remdesivir.  Disposition:SNF
Headache for the past 5 days; This is a spontaneous report from a contactable consumer(patient).A 63-years-old male patient received received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN5318) via an unspecified route of administration in Arm Left on 29Jan2021 10:00 at single dose for covid-19 immunisation.Medical history included subclavian artery stenosis, heart valve replacement, stents; thyroid cancer; Hodgkin's disease .Concomitant medication included clopidogrel ,atorvastatin, warfarin and amlodipine. On 03Feb2021 12:00 the patient experienced headache for the past 5 days with outcome of unknown. The patient did not received treatment for the event. Patient did not receive other vaccine in four weeks. The patient is not covid tested post vaccination. No known allergies were reported for the patient.
Reported to Employee Health office at 12:45, indicating that she did not "feel well" since receiving the flu shot this morning. Complained of onset of "headache" and pain in the right side of her neck radiating down her back. She rated pain as a "5" on pain scale of 0-10. BP-120/72; P-70; R-16; temperature 98.2F. Injection given in left deltoid. There was no redness, swelling or warmth although she reports it does feel "sore". Physician notified and she was given Motrin 400mg po at 12:55. On 10/18/01, no further complaints, it was resolved.